Stockreport

Lantern Pharma Reports Fourth Quarter & Fiscal Year 2023 Financial Results and Business Highlights [Yahoo! Finance]

Lantern Pharma Inc.  (LTRN) 
PDF 2024; with additional next-generation drug development programs approaching IND studies. Dosed initial patients in both Phase 1 clinical trials for synthetic lethal dr [Read more]